Hikma Pharmaceuticals PLC.

In News

Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US - PR Newswire

PR Newswire - Dec 08, 2025

Hikma Pharmaceuticals PLC (LON:HIK) is favoured by institutional owners who hold 59% of the company - Yahoo Finance

Yahoo Finance - Sep 19, 2025

White & Case advises joint lead managers on Hikma Pharmaceuticals’ US$500 million bond issuance - White & Case LLP

White & Case LLP - Jul 23, 2025

Directors’ Deals: Hikma Pharma director eyes recovery - Financial Times

Financial Times - Nov 14, 2025

Hikma Pharma to pay $50 million to settle narcolepsy drug antitrust case - Reuters

Reuters - May 08, 2025

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PR Newswire

PR Newswire - Jun 28, 2025

Hikma Pharmaceuticals Reports 6% Revenue Growth And Confirms FY Outlook - DirectorsTalk Interviews

DirectorsTalk Interviews - Aug 07, 2025

Hikma Pharma tumbles as first-half profits dented by shifting product mix - Proactive financial news

Proactive financial news - Aug 07, 2025

Hikma Pharmaceuticals: Due a dose of confidence - Proactive Investors

Proactive Investors - Nov 12, 2025

Hikma Pharmaceuticals Chairman Acquires Significant Shareholding - TipRanks

TipRanks - Nov 11, 2025

Market Cool On Hikma Pharmaceuticals PLC's (LON:HIK) Earnings - simplywall.st

simplywall.st - Dec 01, 2025

Said Darwazah Acquires 70,000 Shares of Hikma Pharmaceuticals (LON:HIK) Stock - MarketBeat

MarketBeat - Nov 12, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment